Raybow was founded in 2008 as the CDMO division of Jiuzhou Pharmaceutical to provide expert process development and manufacturing for biotech and large pharma clients. Raybow can accommodate a variety of chemistries, including high potency, and offers high quality, efficient and cost-effective services designed to accelerate the drug development process. Raybow manufactures advanced intermediates, regulatory starting materials and active pharmaceutical ingredients in US FDA inspected facilities in Taizhou and Suzhou China and Brevard, NC in the United States. PR&D facilities are located in Hangzhou and Taizhou in China and Brevard, North Carolina in the U.S. Client projects cover all phases of development from pre-clinical to commercial.